{"id":"https://openalex.org/W2803924360","doi":"https://doi.org/10.1097/coc.0000000000000468","title":"Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma","display_name":"Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2803924360","doi":"https://doi.org/10.1097/coc.0000000000000468","mag":"2803924360","pmid":"https://pubmed.ncbi.nlm.nih.gov/29782365","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6240510"},"language":"en","primary_location":{"id":"doi:10.1097/coc.0000000000000468","doi":"https://doi.org/10.1097/coc.0000000000000468","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0000000000000468","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6240510","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090966165","display_name":"David A Becker","orcid":"https://orcid.org/0000-0002-7331-046X","observed_orcids":["https://orcid.org/0000-0002-7331-046X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David A. Becker","raw_affiliation_strings":["Department of Obstetrics & Gynecology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics & Gynecology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006402876","display_name":"Charles Alexander Leath","orcid":"https://orcid.org/0000-0002-4034-6845","observed_orcids":["https://orcid.org/0000-0002-4034-6845"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. Leath","raw_affiliation_strings":["Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113028894","display_name":"C.L. Walters Haygood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christen L. Walters-Haygood","raw_affiliation_strings":["Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071484161","display_name":"Brentley Q. Smith","orcid":"https://orcid.org/0000-0002-8052-0174","observed_orcids":["https://orcid.org/0000-0002-8052-0174"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Brentley Q. Smith","raw_affiliation_strings":["Department of Obstetrics & Gynecology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics & Gynecology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066510200","display_name":"Kerri S. Bevis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerri S. Bevis","raw_affiliation_strings":["Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071484161","https://openalex.org/A5090966165"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5342,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.70239056,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"42","issue":"1","first_page":"12","last_page":"16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intraperitoneal-chemotherapy","display_name":"intraperitoneal chemotherapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9290000200271606},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9959999918937683},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.8119999766349792},{"id":"https://openalex.org/keywords/fallopian-tube-cancer","display_name":"fallopian tube cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/primary-peritoneal-cancer","display_name":"primary peritoneal cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.6100000143051147},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9409999847412109},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8679999709129333},{"id":"https://openalex.org/keywords/port-site-complications","display_name":"port complications","score":0.7059999704360962},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8920000195503235},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9330000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9459832906723022},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7304117679595947},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7232628464698792},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7113300561904907},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5741177797317505},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5383644104003906},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.511163055896759},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5057532787322998},{"id":"https://openalex.org/C2775883341","wikidata":"https://www.wikidata.org/wiki/Q1233836","display_name":"Fallopian tube","level":2,"score":0.46546268463134766},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4556758999824524},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4403117895126343},{"id":"https://openalex.org/C2780435969","wikidata":"https://www.wikidata.org/wiki/Q5625186","display_name":"Gynecologic oncology","level":2,"score":0.4375002980232239},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4176423251628876},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.21757543087005615},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13018548488616943}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005185","descriptor_name":"Fallopian Tube Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005185","descriptor_name":"Fallopian Tube Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010534","descriptor_name":"Peritoneal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010534","descriptor_name":"Peritoneal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/coc.0000000000000468","doi":"https://doi.org/10.1097/coc.0000000000000468","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0000000000000468","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:29782365","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29782365","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Clinical Trial"},{"id":"pmh:oai:europepmc.org:5887967","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6240510","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6240510","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6240510","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Am J Clin Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5887967","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6240510","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1720353554","display_name":"NCTN Deep South Research Consortium","funder_award_id":"U10CA180855","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3552692710","display_name":"OB/GYN Faculty Research Career Development Program","funder_award_id":"K12HD001258","funder_id":"https://openalex.org/F4320337611","funder_display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"},{"id":"https://openalex.org/G9000883787","display_name":"Comprehensive Cancer Center Support Grant","funder_award_id":"P30CA013148","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337611","display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","ror":"https://ror.org/04byxyr05"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1587890193","https://openalex.org/W1849884743","https://openalex.org/W1922469696","https://openalex.org/W1981146671","https://openalex.org/W1998258610","https://openalex.org/W2016888963","https://openalex.org/W2030791200","https://openalex.org/W2043117587","https://openalex.org/W2055914493","https://openalex.org/W2097265582","https://openalex.org/W2101907683","https://openalex.org/W2129949847","https://openalex.org/W2130806638","https://openalex.org/W2150376199","https://openalex.org/W2154175915","https://openalex.org/W2316501478","https://openalex.org/W2329492928","https://openalex.org/W2350476508","https://openalex.org/W2570618306","https://openalex.org/W2770677135","https://openalex.org/W2890238427"],"related_works":["https://openalex.org/W2590632662","https://openalex.org/W1970672025","https://openalex.org/W2908851020","https://openalex.org/W1968679102","https://openalex.org/W2055449166","https://openalex.org/W2055914493","https://openalex.org/W1965594374","https://openalex.org/W1976203128","https://openalex.org/W2056507828","https://openalex.org/W2022157561"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"objective":[2],"of":[3,13,17,41,63,117,151,160,177],"this":[4,121],"study":[5,40],"was":[6,147,167,184,198,215,225],"to":[7],"report":[8],"the":[9,206],"tolerability":[10,98,241],"and":[11,21,25,68,88,93,97,132,171],"toxicity":[12],"a":[14,37],"regimen":[15,61,237],"consisting":[16,62],"intravenous":[18],"(IV)":[19],"docetaxel":[20,64],"intraperitoneal":[22],"(IP)":[23],"cisplatin":[24,69],"paclitaxel":[26,77],"with":[27,43,56,158,209,244],"granulocyte":[28],"colony-stimulating":[29],"factor":[30],"support.":[31],"MATERIALS":[32],"AND":[33],"METHODS:":[34],"We":[35],"conducted":[36],"retrospective":[38],"cohort":[39],"patients":[42,119,136,183,197,208],"surgical":[44],"stage":[45,210],"II-IV":[46],"epithelial":[47],"ovarian,":[48],"fallopian":[49],"tube":[50],"or":[51,145],"primary":[52],"peritoneal":[53],"carcinoma":[54],"treated":[55],"an":[57,239],"outpatient":[58],"IP":[59,72,80,122,140,235,250],"chemotherapy":[60,236],"75":[65,70],"mg/m":[66,71,79],"IV":[67],"day":[73,81],"1":[74],"followed":[75],"by":[76],"60":[78,118],"8":[82],"every":[83],"21":[84],"days.":[85],"Grade":[86],"3":[87],"4":[89],"toxicity,":[90],"dose":[91],"delays":[92],"reductions,":[94],"port":[95,141],"complications,":[96],"are":[99,111,173,262],"reported.":[100,113],"Outcomes,":[101],"including":[102],"response":[103,166],"rate,":[104],"progression-free":[105],"survival":[106,109,258],"(PFS),":[107],"overall":[108],"(OS)":[110],"also":[112],"RESULTS:":[114],"A":[115],"total":[116,161],"received":[120],"regimen.":[123],"Most":[124,135],"common":[125],"toxicities":[126],"included":[127],"neutropenia":[128],"(47%),":[129],"gastrointestinal":[130],"(28%),":[131],"anemia":[133],"(25%).":[134],"(85%)":[137],"experienced":[138],"no":[139],"complications.":[142],"Dose":[143],"delay":[144],"reduction":[146],"required":[148],"in":[149],"30%":[150],"patients.":[152],"Two-thirds":[153],"completed":[154],"all":[155,182,196],"prescribed":[156],"cycles,":[157],"80%":[159],"planned":[162],"cycles":[163],"completed.":[164],"Complete":[165],"achieved":[168],"for":[169,181,195],"88%,":[170],"43%":[172],"currently":[174],"without":[175],"evidence":[176],"disease.":[178],"Median":[179],"PFS":[180,214],"25.5":[185],"months":[186,200,217,227],"(95%":[187,201,218,228],"confidence":[188],"interval":[189],"[CI],":[190],"20.4-30.5":[191],"mo)":[192],"while":[193,222],"OS":[194,224],"56.8":[199,226],"CI,":[202,219,229],"47.7-65.9":[203],"mo).":[204,231],"For":[205],"44":[207],"III":[211],"disease,":[212],"median":[213,223],"22.1":[216],"16.3-28.0":[220],"mo),":[221],"47.3-66.3":[230],"CONCLUSIONS:":[232],"This":[233],"docetaxel-based":[234],"demonstrates":[238],"improved":[240],"profile":[242],"compared":[243],"GOG172.":[245],"Additional":[246],"evaluations":[247],"on":[248],"alternative":[249],"regimens":[251],"remain":[252],"warranted.":[253],"Short":[254],"follow-up":[255],"time":[256],"limits":[257],"assessment,":[259],"but":[260],"results":[261],"encouraging.":[263]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-06-01T00:00:00"}